Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Self-reported hearing quality of life measures in pediatric cochlear implant recipients with bilateral input.

Suneel D, Davidson LS, Lieu J.

Cochlear Implants Int. 2020 Mar;21(2):83-91. doi: 10.1080/14670100.2019.1670486. Epub 2019 Oct 7.

PMID:
31590628
2.

Effects of Early Acoustic Hearing on Speech Perception and Language for Pediatric Cochlear Implant Recipients.

Davidson LS, Geers AE, Uchanski RM, Firszt JB.

J Speech Lang Hear Res. 2019 Sep 20;62(9):3620-3637. doi: 10.1044/2019_JSLHR-H-18-0255. Epub 2019 Sep 13.

3.

The Effect of Cochlear Implant Interval on Spoken Language Skills of Pediatric Bilateral Cochlear Implant Users.

Wenrich KA, Davidson LS, Uchanski RM.

Otol Neurotol. 2019 Jul;40(6):e600-e605. doi: 10.1097/MAO.0000000000002245.

PMID:
31135675
4.

Preimplant Hearing Aid Fittings and Aided Audibility for Pediatric Cochlear Implant Recipients.

Nickerson A, Davidson LS, Uchanski RM.

J Am Acad Audiol. 2019 Sep;30(8):703-711. doi: 10.3766/jaaa.17126. Epub 2019 Apr 17.

PMID:
31044697
5.

Effects of Early Auditory Deprivation on Working Memory and Reasoning Abilities in Verbal and Visuospatial Domains for Pediatric Cochlear Implant Recipients.

Davidson LS, Geers AE, Hale S, Sommers MM, Brenner C, Spehar B.

Ear Hear. 2019 May/Jun;40(3):517-528. doi: 10.1097/AUD.0000000000000629.

PMID:
31026238
6.

Segmental and Suprasegmental Perception in Children Using Hearing Aids.

Wenrich KA, Davidson LS, Uchanski RM.

J Am Acad Audiol. 2017 Nov/Dec;28(10):901-912. doi: 10.3766/jaaa.16105.

7.

The Effects of Auditory Contrast Tuning upon Speech Intelligibility.

Killian NJ, Watkins PV, Davidson LS, Barbour DL.

Front Psychol. 2016 Aug 9;7:1145. doi: 10.3389/fpsyg.2016.01145. eCollection 2016.

8.

The Effects of Preprocessing Strategies for Pediatric Cochlear Implant Recipients.

Rakszawski B, Wright R, Cadieux JH, Davidson LS, Brenner C.

J Am Acad Audiol. 2016 Feb;27(2):85-102. doi: 10.3766/jaaa.14058.

9.

Evaluation of hearing aid frequency response fittings in pediatric and young adult bimodal recipients.

Davidson LS, Firszt JB, Brenner C, Cadieux JH.

J Am Acad Audiol. 2015 Apr;26(4):393-407. doi: 10.3766/jaaa.26.4.7.

10.

The effects of audibility and novel word learning ability on vocabulary level in children with cochlear implants.

Davidson LS, Geers AE, Nicholas JG.

Cochlear Implants Int. 2014 Jul;15(4):211-21. doi: 10.1179/1754762813Y.0000000051. Epub 2013 Nov 25.

11.

Interdependence of linguistic and indexical speech perception skills in school-age children with early cochlear implantation.

Geers AE, Davidson LS, Uchanski RM, Nicholas JG.

Ear Hear. 2013 Sep;34(5):562-74. doi: 10.1097/AUD.0b013e31828d2bd6.

12.

A longitudinal study of speech perception skills and device characteristics of adolescent cochlear implant users.

Robinson EJ, Davidson LS, Uchanski RM, Brenner CM, Geers AE.

J Am Acad Audiol. 2012 May;23(5):341-9. doi: 10.3766/jaaa.23.5.5.

13.

Factors contributing to speech perception scores in long-term pediatric cochlear implant users.

Davidson LS, Geers AE, Blamey PJ, Tobey EA, Brenner CA.

Ear Hear. 2011 Feb;32(1 Suppl):19S-26S. doi: 10.1097/AUD.0b013e3181ffdb8b.

14.

Cochlear implant characteristics and speech perception skills of adolescents with long-term device use.

Davidson LS, Geers AE, Brenner C.

Otol Neurotol. 2010 Oct;31(8):1310-4. doi: 10.1097/MAO.0b013e3181eb320c.

15.

Two ears and two (or more?) devices: a pediatric case study of bilateral profound hearing loss.

Uchanski RM, Davidson LS, Quadrizius S, Reeder R, Cadieux J, Kettel J, Chole RA.

Trends Amplif. 2009 Jun;13(2):107-23. doi: 10.1177/1084713809336423.

16.

The effect of instantaneous input dynamic range setting on the speech perception of children with the nucleus 24 implant.

Davidson LS, Skinner MW, Holstad BA, Fears BT, Richter MK, Matusofsky M, Brenner C, Holden T, Birath A, Kettel JL, Scollie S.

Ear Hear. 2009 Jun;30(3):340-9. doi: 10.1097/AUD.0b013e31819ec93a.

PMID:
19322085
17.

Relation of electrically evoked compound action potential thresholds to behavioral T- and C-levels in children with cochlear implants.

Holstad BA, Sonneveldt VG, Fears BT, Davidson LS, Aaron RJ, Richter M, Matusofsky M, Brenner CA, Strube MJ, Skinner MW.

Ear Hear. 2009 Feb;30(1):115-27. doi: 10.1097/AUD.0b013e3181906c0f.

PMID:
19125034
18.

Audibility and speech perception of children using wide dynamic range compression hearing AIDS.

Davidson LS, Skinner MW.

Am J Audiol. 2006 Dec;15(2):141-53.

PMID:
17182879
20.

Effects of communication mode on skills of long-term cochlear implant users.

Geers AE, Nicholas J, Tye-Murray N, Uchanski R, Brenner C, Davidson LS, Toretta G, Tobey EA.

Ann Otol Rhinol Laryngol Suppl. 2000 Dec;185:89-92. No abstract available.

PMID:
11141021
21.

Predicting speech perception benefit from loudness growth measures and other map characteristics of the nucleus 22 implant.

Davidson LS, Brenner C, Geers AE.

Ann Otol Rhinol Laryngol Suppl. 2000 Dec;185:56-8. No abstract available.

PMID:
11141004
22.

Incontinentia pigmenti: three cases with unusual features.

Sahn EE, Davidson LS.

J Am Acad Dermatol. 1994 Nov;31(5 Pt 2):852-7.

PMID:
7962735
23.

Plasmid carriage in Vibrio vulnificus and other lactose-fermenting marine vibrios.

Davidson LS, Oliver JD.

Appl Environ Microbiol. 1986 Jul;52(1):211-3.

24.

Apologies to the unsung heroes--the volunteers.

Davidson LS.

Hospitals. 1978 Feb 16;52(4):64, 68. No abstract available.

PMID:
621038
25.

Clean food.

DAVIDSON LS.

Proc Nutr Soc. 1957;16(2):135-6. No abstract available.

PMID:
13465700
26.

African journey: a physician's impressions of a trip from Cape Town to Cairo.

DAVIDSON LS.

Lancet. 1954 Mar 20;266(6812):614-7. No abstract available.

PMID:
13143737
27.

Megaloblastic anaemia and subacute combined degeneration from tuberculous disease of the small intestine.

DAVIDSON LS.

Gastroenterologia. 1953 Jun;79(6):342-3. No abstract available.

PMID:
13083803
28.

Effect of A.C.T.H. and cortisone therapy in blood disorders.

DAVIDSON LS, GIRDWOOD RH, SWAN HT.

Br Med J. 1952 Nov 15;2(4793):1059-63. No abstract available.

29.

Thirty years' experience of the megaloblastic anaemias.

DAVIDSON LS.

Edinb Med J. 1952 Jul;59(7):315-26. No abstract available.

30.

Treatment of the megaloblastic anaemias with citrovorum factor.

DAVIDSON LS, GIRDWOOD RH.

Lancet. 1951 Dec 29;2(6696):1193-5. No abstract available.

PMID:
14881605
31.

Advances in the treatment of blood diseases.

DAVIDSON LS, INNES J.

Practitioner. 1951 Oct;167(1000):375-81. No abstract available.

PMID:
14875597
32.

Clinical trials of ACTH in haemolytic anaemia.

DAVIDSON LS, DUTHIE JJ, GIRDWOOD RH, SINCLAIR RJ.

Br Med J. 1951 Mar 31;1(4708):657-60. No abstract available.

33.

Treatment of pernicious anaemia with Leuconostoc citrovorum factor.

DAVIDSON LS, GIRDWOOD RH.

Lancet. 1951 Mar 31;1(6657):722-3. No abstract available.

PMID:
14814845
34.

The physiological and clinical effects of cortisone and the adrenocorticotrophic hormone (ACTH).

DAVIDSON LS.

Edinb Med J. 1950 Aug;57(8):317-40. No abstract available.

35.

Purpura in pregnancy with special reference to idiopathic thrombocytopenic purpura.

ROBSON HN, DAVIDSON LS.

Lancet. 1950 Jul 29;2(6622):164-9. No abstract available.

PMID:
15437910
36.

Incidence of the sprue syndrome; with some observations on the natural history.

DAVIDSON LS, FOUNTAIN JR.

Br Med J. 1950 May 20;1(4663):1157-61. No abstract available.

37.

A case of cyclic neutropenia.

ROLLAND CF, DAVIDSON LS.

Edinb Med J. 1950 May;57(5):205-10. No abstract available.

38.

The use and abuse of vitamins.

DAVIDSON LS.

Br Med J. 1949 Nov 5;2(4635):1036-8. No abstract available.

40.

Mercaptan in the breath of patients with severe liver disease.

DAVIDSON LS.

Lancet. 1949 Jul 30;2(6570):197. No abstract available.

PMID:
18136275
41.

Ehrlich's aldehyde test for urobilinogen.

WILSON TM, DAVIDSON LS.

Br Med J. 1949 May 21;1(4611):884-7. No abstract available.

42.

Pteroylglutamic acid; indications and limitations.

DAVIDSON LS.

Edinb Med J. 1948 Jul;55(7):400-11. No abstract available.

43.

Activity of liver extracts.

DAVIDSON LS.

Br Med J. 1948 May 29;1(4560):1050. No abstract available.

44.

El ácido fólico como agente terapéutico.

DAVIDSON LS, GIRDWOOD RH.

Dia Med. 1948 May 17;20(22):822-9. Undetermined Language. No abstract available.

PMID:
18873730
45.

Pernicious anaemia of pregnancy and the puerperium.

DAVIDSON LS, GIRDWOOD RH, CLARK JR.

Br Med J. 1948 May 1;1(4556):819-22. No abstract available.

46.

Refractory iron-deficiency anaemia treated with intravenous saccharated oxide of iron.

DAVIDSON LS, GIRDWOOD RH.

Br Med J. 1948 Apr 17;1(4554):733. No abstract available.

47.

The imbalance of vitamins with particular reference to folic acid.

DAVIDSON LS, GIRDWOOD RH.

Lancet. 1948 Mar 6;1(6497):360-3. No abstract available.

PMID:
18904275
48.

Refractory megaloblastic anemia.

DAVIDSON LS.

Blood. 1948 Jan;3(1):107-20. No abstract available.

PMID:
18920895
49.

Advances in the treatment of blood diseases.

DAVIDSON LS.

Practitioner. 1947 Oct;159(952):311-9. No abstract available.

PMID:
20265360
50.

Folic acid as a therapeutic agent.

DAVIDSON LS, GIRDWOOD RH.

Br Med J. 1947 May 3;1(4504):587-91. No abstract available.

Supplemental Content

Loading ...
Support Center